Kelly Paul Edward 4
4 · RELMADA THERAPEUTICS, INC. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Kelly Paul Edward
DirectorChief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-03$3.24/sh−20,000$64,800→ 187,295 total - Exercise/Conversion
Options to purchase common stock
2022-01-03−20,000→ 30,500 totalExercise: $3.24From: 2017-10-20Exp: 2027-10-20→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.
- [F2]Not applicable.